Skip to content

Author

N. Rangel

We have 2 of 36 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

FOXA1 expression and survival outcomes in triple-negative breast cancer: A retrospective cohort study

Triple-negative breast cancer (TNBC) remains the most aggressive breast cancer subtype, with the poorest prognosis among all forms of breast cancer. FOXA1 is a well-known pioneer factor in luminal breast cancer, however, despite its vital role in this tumor subtype, detailed information about FOXA1 expression and funct...

A. Fonseca-Benítez, David Díaz-Báez, Giulia Capella et al. · 0 citations
Open access Aug 2026

Single-Cell RNA-Seq Reveals Chromosomal Instability-Associated Transcriptomic Profiles in Breast Cancer

Single-cell approaches such as scRNA-seq provide a powerful framework to elucidate CIN-related mechanisms and to identify potential biomarkers of BC aggressiveness and prognosis, supporting their further application in the study of intratumoral heterogeneity.

María Paula Meléndez-Flórez, N. Rangel, Milena Rondón-Lagos et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.